USA – The National Institutes of Health (NIH) and the Centers for Medicare & Medicaid Services (CMS) have joined forces in a major new initiative to study autism spectrum disorder (ASD). The project is part of a broader push by Health and Human Services Secretary Robert F. Kennedy Jr. to better understand what causes autism […]
KENYA – Gertrude’s Children’s Hospital in Nairobi has unveiled a modern Radiology Centre dedicated to providing advanced imaging services designed specifically for children. This new facility marks a significant step forward in pediatric diagnostics, combining cutting-edge technology with a focus on comfort, safety, and quality care. The Radiology Centre is equipped with top-tier imaging tools, […]
KENYA – RFH Healthcare has made medical history by becoming the first hospital in Kenya, and across East Africa, to offer a highly targeted cancer treatment known as Lutetium therapy. Located in Ruai, Nairobi, the facility is now providing advanced care for patients with late-stage prostate cancer, eliminating the need for costly travel abroad. The […]
USA – Eli Lilly has joined forces with BigHat Biosciences in a new partnership aimed at developing advanced antibody-based medicines using artificial intelligence. The collaboration, which involves up to two antibody programs, highlights Lilly’s continued investment in AI-driven drug discovery. BigHat will lead the design and engineering of the antibodies using its powerful Milliner platform. […]
USA – Gilead Sciences has announced a major expansion of its U.S. operations, committing an additional US $11 billion to boost its manufacturing and research footprint. This move brings the company’s total planned investment in the U.S. to US $32 billion over the next five years. The biotech giant says the new funding will support […]
USA – Novo Nordisk is moving closer to making history with the first FDA-approved weight-loss pill based on GLP-1. On Friday, the U.S. Food and Drug Administration accepted Novo’s New Drug Application for an oral version of Wegovy, its well-known injectable obesity drug. If approved, the new tablet would offer adults with obesity or overweight […]
SWITZERLAND – The World Health Organization (WHO) is considering a significant policy shift by potentially including obesity medications, such as Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound, in its Essential Medicines List (EML). This move aims to address the escalating global obesity crisis, which affects over a billion people worldwide, with 70% residing in low- […]
GERMANY – BioNTech is advancing toward its first cancer drug approval with BNT323, a HER2-targeted antibody-drug conjugate (ADC) developed in collaboration with China’s Duality Biologics. The company plans to submit a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) in 2025 for the treatment of advanced endometrial cancer. BNT323, also known […]
USA – Bristol Myers Squibb (BMS) is set to invest US $40 billion in the United States over the next five years to expand its research and manufacturing operations. The announcement was made by BMS CEO Christopher Boerner in an opinion piece published in Stat News. He explained that the funds will support research and […]
USA – Vertex Pharmaceuticals is seeing early success with its newly approved non-opioid pain drug, Journavx, which has already racked up around 25,000 prescriptions since gaining FDA approval in January. The drug works by targeting specific sodium channels in the nerves, stopping pain signals before they reach the brain. This sets it apart from opioids, […]
CHINA – Hong Kong has unveiled a new initiative aimed at streamlining the process for technology and biotechnology companies to list on its stock exchange. The “Technology Enterprises Channel,” announced jointly by the Hong Kong Exchanges and Clearing (HKEX) and the Securities and Futures Commission (SFC), is designed to attract more Chinese firms seeking to […]
GERMANY – Siemens AG has signed a definitive agreement to acquire Dotmatics, a Boston-based leader in life sciences R&D software, for US $5.1 billion from Insight Partners. This move marks a major step in Siemens’ strategic expansion into the life sciences sector, enhancing its industrial software portfolio with Dotmatics’ cutting-edge scientific intelligence platform. The acquisition […]
XRP HEALTHCARE L.L.C | License Number: 2312867.01 | Dubai | © Copyright 2025 | All Rights Reserved